Frenetic activity won't fix the pharmaceutical industry's problems

 

Outlook The pharmaceutical sector is creating more excitement in the world's financial centres than the opening of a warehouse full of free Viagra in a retirement community.

That drug's American maker, Pfizer, is said to have played footsie with AstraZeneca over the possibility of a blockbuster bid. At the same time European rivals Glaxo and Novartis are hoping to cure what ails them by playing a game of billion-dollar swapsies.

Both appear to make sense, at least on the face of it.

It's not warehouses full of its signature drug that Pfizer needs to dispose of so much as it is the warehouses full of cash that the company has stashed overseas.

Spending that money outside the US is logical because of the cut Uncle Sam would take were it to flow back home. Hence the news of an approach to Astra. It helps that some analysts feel Astra is a prime target on account of its being under-valued by European investors, who, let's face it, are probably feeling more than a little bruised by the company's hugely disappointing recent history combined with the prospect of five years of falling revenues.

Astra's shareholders might be very interested in hearing what Pfizer has to say. But what about Pfizer's shareholders? Their company's market capitalisation is now less than the amount of their money it used to pay for three previous mega-deals. Blockbuster drugs might generate shareholder value but, as a rule, blockbuster deals don't.

Which brings us to Glaxo and Novartis. Bribery allegations have left the former, once the bluest of blue chips, looking a bit grey of late. Promising shareholders a $4bn (£2.37bn) bung as a result of it shaking its portfolio up should at least stop them from fretting too much in the short term.

So Glaxo is selling its subscale cancer drugs business to Norvartis for what looks like a tasty price. The latter, meanwhile, is sending its vaccines business (minus 'flu) in the opposite direction, while the two are combining their consumer-products operations with Glaxo in the driving seat. Glaxo also gets a transfer fee as a result of the swap, some of which is earmarked for the shareholder largesse I mentioned. Phew!

This is about both focusing on what they're really good at, an eminently sensible strategy, and both could ultimately emerge as winners from the deal.

But none of this frenetic activity fixes the industry's core problems. They are its continuing struggles to replace one-time blockbuster drugs whose patents are expiring with similarly lucrative new treatments combined with the harsh spotlight that is being shone on industry practices.

All this pharma M&A could easily be compared to Tamiflu, the controversial 'flu drug made by Roche: It only treats symptoms, and even its effectiveness against them is questionable. Plus it's expensive, and there are side effects that can make the patient feel worse than the illness.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Telesales Executive - OTE £25,000

£13000 - £25000 per annum: Recruitment Genius: Would you like to be part of a ...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: Are you passionate about sale...

Ashdown Group: Graduate Developer (Trainee) - City, London

£25000 per annum + benefits: Ashdown Group: A large financial services company...

Ashdown Group: Marketing Assistant - Financial Services Sector - London

£20400 per annum: Ashdown Group: An established and highly reputable organisat...

Day In a Page

The Silk Roads that trace civilisation: Long before the West rose to power, Asian pathways were connecting peoples and places

The Silk Roads that trace civilisation

Long before the West rose to power, Asian pathways were connecting peoples and places
House of Lords: Outcry as donors, fixers and MPs caught up in expenses scandal are ennobled

The honours that shame Britain

Outcry as donors, fixers and MPs caught up in expenses scandal are ennobled
When it comes to street harassment, we need to talk about race

'When it comes to street harassment, we need to talk about race'

Why are black men living the stereotypes and why are we letting them get away with it?
International Tap Festival: Forget Fred Astaire and Ginger Rogers - this dancing is improvised, spontaneous and rhythmic

International Tap Festival comes to the UK

Forget Fred Astaire and Ginger Rogers - this dancing is improvised, spontaneous and rhythmic
War with Isis: Is Turkey's buffer zone in Syria a matter of self-defence – or just anti-Kurd?

Turkey's buffer zone in Syria: self-defence – or just anti-Kurd?

Ankara accused of exacerbating racial division by allowing Turkmen minority to cross the border
Doris Lessing: Acclaimed novelist was kept under MI5 observation for 18 years, newly released papers show

'A subversive brothel keeper and Communist'

Acclaimed novelist Doris Lessing was kept under MI5 observation for 18 years, newly released papers show
Big Blue Live: BBC's Springwatch offshoot swaps back gardens for California's Monterey Bay

BBC heads to the Californian coast

The Big Blue Live crew is preparing for the first of three episodes on Sunday night, filming from boats, planes and an aquarium studio
Austin Bidwell: The Victorian fraudster who shook the Bank of England with the most daring forgery the world had known

Victorian fraudster who shook the Bank of England

Conman Austin Bidwell. was a heartless cad who carried out the most daring forgery the world had known
Car hacking scandal: Security designed to stop thieves hot-wiring almost every modern motor has been cracked

Car hacking scandal

Security designed to stop thieves hot-wiring almost every modern motor has been cracked
10 best placemats

Take your seat: 10 best placemats

Protect your table and dine in style with a bold new accessory
Ashes 2015: Alastair Cook not the only one to be caught in The Oval mindwarp

Cook not the only one to be caught in The Oval mindwarp

Aussie skipper Michael Clarke was lured into believing that what we witnessed at Edgbaston and Trent Bridge would continue in London, says Kevin Garside
Can Rafael Benitez get the best out of Gareth Bale at Real Madrid?

Can Benitez get the best out of Bale?

Back at the club he watched as a boy, the pressure is on Benitez to find a winning blend from Real's multiple talents. As La Liga begins, Pete Jenson asks if it will be enough to stop Barcelona
Athletics World Championships 2015: Beijing witnesses new stage in the Jessica Ennis-Hill and Katarina Johnson-Thompson heptathlon rivalry

Beijing witnesses new stage in the Jess and Kat rivalry

The last time the two British heptathletes competed, Ennis-Hill was on the way to Olympic gold and Johnson-Thompson was just a promising teenager. But a lot has happened in the following three years
Jeremy Corbyn: Joining a shrewd operator desperate for power as he visits the North East

Jeremy Corbyn interview: A shrewd operator desperate for power

His radical anti-austerity agenda has caught the imagination of the left and politically disaffected and set a staid Labour leadership election alight
Isis executes Palmyra antiquities chief: Defender of ancient city's past was killed for protecting its future

Isis executes Palmyra antiquities chief

Robert Fisk on the defender of the ancient city's past who was killed for protecting its future